Have a personal or library account? Click to login
Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis Cover

Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis

Open Access
|Jan 2023

Authors

Ahmed F. Mady

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Anaesthesia Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Basheer Abdulrahman

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Shahzad A. Mumtaz

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Mohammed A. Al-Odat

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Ahmed Kuhail

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Rehab Altoraifi

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Rayan Alshae

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Abdulrahman M. Alharthy

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia

Dimitrios Karakitsos

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Department of Medicine, South Carolina University School of Medicine, Columbia, USA
Critical Care Department, Keck School of Medicine, University of Southern California, Los Angeles, USA

Waleed Th. Aletreby

waleedaletreby@gmail.com

Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
DOI: https://doi.org/10.2478/rjaic-2022-0001 | Journal eISSN: 2502-0307 | Journal ISSN: 2392-7518
Language: English
Page range: 1 - 7
Published on: Jan 14, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2023 Ahmed F. Mady, Basheer Abdulrahman, Shahzad A. Mumtaz, Mohammed A. Al-Odat, Ahmed Kuhail, Rehab Altoraifi, Rayan Alshae, Abdulrahman M. Alharthy, Dimitrios Karakitsos, Waleed Th. Aletreby, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.